253 related articles for article (PubMed ID: 11722677)
1. DNA topoisomerases as targets for anticancer drugs.
Topcu Z
J Clin Pharm Ther; 2001 Dec; 26(6):405-16. PubMed ID: 11722677
[TBL] [Abstract][Full Text] [Related]
2. Exploring DNA topoisomerases as targets of novel therapeutic agents in the treatment of infectious diseases.
Tse-Dinh YC
Infect Disord Drug Targets; 2007 Mar; 7(1):3-9. PubMed ID: 17346206
[TBL] [Abstract][Full Text] [Related]
3. Analysis of eukaryotic DNA topoisomerases and topoisomerase-directed drug effects.
Boege F
Eur J Clin Chem Clin Biochem; 1996 Nov; 34(11):873-88. PubMed ID: 8960461
[TBL] [Abstract][Full Text] [Related]
4. The response of eukaryotic topoisomerases to DNA damage.
Kingma PS; Osheroff N
Biochim Biophys Acta; 1998 Oct; 1400(1-3):223-32. PubMed ID: 9748592
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of cell killing by drugs that trap covalent complexes between DNA topoisomerases and DNA.
Nitiss JL; Wang JC
Mol Pharmacol; 1996 Nov; 50(5):1095-102. PubMed ID: 8913340
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the development of dual topoisomerase I and II inhibitors as anticancer drugs.
Salerno S; Da Settimo F; Taliani S; Simorini F; La Motta C; Fornaciari G; Marini AM
Curr Med Chem; 2010; 17(35):4270-90. PubMed ID: 20939813
[TBL] [Abstract][Full Text] [Related]
7. Topoisomerase Inhibitors and Targeted Delivery in Cancer Therapy.
You F; Gao C
Curr Top Med Chem; 2019; 19(9):713-729. PubMed ID: 30931860
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of resistance in a human cell line exposed to sequential topoisomerase poisoning.
Saleem A; Ibrahim N; Patel M; Li XG; Gupta E; Mendoza J; Pantazis P; Rubin EH
Cancer Res; 1997 Nov; 57(22):5100-6. PubMed ID: 9371509
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of resistance to topoisomerases poisons.
Prost S
Gen Pharmacol; 1995 Dec; 26(8):1773-84. PubMed ID: 8745168
[TBL] [Abstract][Full Text] [Related]
10. DNA topoisomerases as targets for the anticancer drug TAS-103: DNA interactions and topoisomerase catalytic inhibition.
Fortune JM; Velea L; Graves DE; Utsugi T; Yamada Y; Osheroff N
Biochemistry; 1999 Nov; 38(47):15580-6. PubMed ID: 10569942
[TBL] [Abstract][Full Text] [Related]
11. [Poisons of DNA topoisomerases I and II].
Charcosset JY; Soues S; Laval F
Bull Cancer; 1993 Nov; 80(11):923-54. PubMed ID: 8081034
[TBL] [Abstract][Full Text] [Related]
12. Topoisomerase inhibitors as anticancer agents: a patent update.
Khadka DB; Cho WJ
Expert Opin Ther Pat; 2013 Aug; 23(8):1033-56. PubMed ID: 23611704
[TBL] [Abstract][Full Text] [Related]
13. DNA topoisomerases from pathogenic fungi: targets for the discovery of antifungal drugs.
Shen LL; Baranowski J; Fostel J; Montgomery DA; Lartey PA
Antimicrob Agents Chemother; 1992 Dec; 36(12):2778-84. PubMed ID: 1336349
[TBL] [Abstract][Full Text] [Related]
14. DNA topoisomerases from Streptomyces noursei: influence of coumarins and quinolones on the enzymic activity.
Störl K; Störl J; Roth M; Zimmer C
Biochim Biophys Acta; 1994 Mar; 1199(2):143-8. PubMed ID: 8123663
[TBL] [Abstract][Full Text] [Related]
15. DNA topoisomerases: from a laboratory curiosity to a subject in cancer chemotherapy.
Wang JC
NCI Monogr; 1987; (4):3-6. PubMed ID: 2819727
[TBL] [Abstract][Full Text] [Related]
16. Topoisomerases, new targets in cancer chemotherapy.
Zijlstra JG; de Jong S; de Vries EG; Mulder NH
Med Oncol Tumor Pharmacother; 1990; 7(1):11-8. PubMed ID: 2160032
[TBL] [Abstract][Full Text] [Related]
17. DNA topoisomerases and topoisomerase inhibitors.
Giaccone G
Pathol Biol (Paris); 1994 Apr; 42(4):346-52. PubMed ID: 7808789
[TBL] [Abstract][Full Text] [Related]
18. Multiple Topoisomerase I (TopoI), Topoisomerase II (TopoII) and Tyrosyl-DNA Phosphodiesterase (TDP) inhibitors in the development of anticancer drugs.
Baglini E; Salerno S; Barresi E; Robello M; Da Settimo F; Taliani S; Marini AM
Eur J Pharm Sci; 2021 Jan; 156():105594. PubMed ID: 33059042
[TBL] [Abstract][Full Text] [Related]
19. Various inhibitors of DNA topoisomerases diminish repair-specific DNA incision in UV-irradiated human fibroblasts.
Thielmann HW; Popanda O; Gersbach H; Gilberg F
Carcinogenesis; 1993 Nov; 14(11):2341-51. PubMed ID: 8242865
[TBL] [Abstract][Full Text] [Related]
20. Topoisomerases as anticancer targets.
Delgado JL; Hsieh CM; Chan NL; Hiasa H
Biochem J; 2018 Jan; 475(2):373-398. PubMed ID: 29363591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
